17-65053580-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_006572.6(GNA13):āc.432A>Gā(p.Gln144=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0124 in 1,613,844 control chromosomes in the GnomAD database, including 154 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0097 ( 5 hom., cov: 33)
Exomes š: 0.013 ( 149 hom. )
Consequence
GNA13
NM_006572.6 synonymous
NM_006572.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.01
Genes affected
GNA13 (HGNC:4381): (G protein subunit alpha 13) Predicted to enable D5 dopamine receptor binding activity; G-protein beta/gamma-subunit complex binding activity; and GTPase activity. Predicted to be involved in several processes, including Rho protein signal transduction; activation of phospholipase D activity; and multicellular organism aging. Predicted to act upstream of or within several processes, including branching involved in blood vessel morphogenesis; negative regulation of vascular associated smooth muscle cell migration; and negative regulation of vascular associated smooth muscle cell proliferation. Located in cytosol and nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 17-65053580-T-C is Benign according to our data. Variant chr17-65053580-T-C is described in ClinVar as [Benign]. Clinvar id is 789341.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.01 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.00965 (1470/152326) while in subpopulation AMR AF= 0.024 (367/15292). AF 95% confidence interval is 0.022. There are 5 homozygotes in gnomad4. There are 685 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1470 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GNA13 | NM_006572.6 | c.432A>G | p.Gln144= | synonymous_variant | 2/4 | ENST00000439174.7 | |
GNA13 | NM_001282425.2 | c.147A>G | p.Gln49= | synonymous_variant | 2/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GNA13 | ENST00000439174.7 | c.432A>G | p.Gln144= | synonymous_variant | 2/4 | 1 | NM_006572.6 | P1 | |
GNA13 | ENST00000541118.1 | c.147A>G | p.Gln49= | synonymous_variant | 2/4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00964 AC: 1467AN: 152208Hom.: 5 Cov.: 33
GnomAD3 genomes
AF:
AC:
1467
AN:
152208
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0110 AC: 2756AN: 251494Hom.: 26 AF XY: 0.00998 AC XY: 1356AN XY: 135922
GnomAD3 exomes
AF:
AC:
2756
AN:
251494
Hom.:
AF XY:
AC XY:
1356
AN XY:
135922
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0127 AC: 18619AN: 1461518Hom.: 149 Cov.: 30 AF XY: 0.0123 AC XY: 8939AN XY: 727106
GnomAD4 exome
AF:
AC:
18619
AN:
1461518
Hom.:
Cov.:
30
AF XY:
AC XY:
8939
AN XY:
727106
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00965 AC: 1470AN: 152326Hom.: 5 Cov.: 33 AF XY: 0.00920 AC XY: 685AN XY: 74480
GnomAD4 genome
AF:
AC:
1470
AN:
152326
Hom.:
Cov.:
33
AF XY:
AC XY:
685
AN XY:
74480
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
10
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 16, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at